专题：SARS-CoV-2 and COVID-19 Research

This cluster of papers focuses on the research related to the coronavirus disease 2019 (COVID-19), including topics such as SARS-CoV-2, vaccine development, spike protein structure, antibody responses, viral mutations, and immune protection. The papers cover various aspects of the pandemic, from virus transmission to potential therapeutic targets.
最新文献
Coronavirus Disease (COVID-19)

book-chapter Full Text OpenAlex

Addressing Vaccine Hesitancy in the Age of Measles Resurgence: A Mini-Review

article Full Text OpenAlex

Coronavirus Disease (COVID-19)

book-chapter Full Text OpenAlex

Viral evolution prediction identifies broadly neutralizing antibodies to existing and prospective SARS-CoV-2 variants

article Full Text OpenAlex

Post-Marketing Surveillance of Nirsevimab: Safety Profile and Adverse Event Analysis from Spain’s 2023–2024 RSV Immunisation Campaign

article Full Text OpenAlex

Awareness and willingness towards Mpox vaccination among men who have sex with men seeking HIV-related services

article Full Text OpenAlex

Strategy to overcome a nirmatrelvir resistance mechanism in the SARS-CoV-2 nsp5 protease

article Full Text OpenAlex

Antigenic and virological characteristics of SARS-CoV-2 variants BA.3.2, XFG, and NB.1.8.1

letter Full Text OpenAlex

Comparing Moderna’s mRNA-1083 and Pfizer’s dual-target mRNA vaccines for influenza and COVID-19

review Full Text OpenAlex

Immunogenicity and adverse effects of pneumococcal vaccines co-administered with influenza or SARS-CoV-2 vaccines in adults: A systematic review and Meta-analysis

review Full Text OpenAlex

近5年高被引文献
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

article Full Text OpenAlex 3848 FWCI241.376

SARS-CoV-2 variants, spike mutations and immune escape

review Full Text OpenAlex 3513 FWCI103.379

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

article Full Text OpenAlex 2944 FWCI190.542

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection

article Full Text OpenAlex 2783 FWCI176.895

Mechanisms of SARS-CoV-2 entry into cells

review Full Text OpenAlex 2677 FWCI72.548

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

article Full Text OpenAlex 2597 FWCI165.884

Lipid nanoparticles for mRNA delivery

review Full Text OpenAlex 2532 FWCI56.857

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

article Full Text OpenAlex 2475 FWCI159.423

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

article Full Text OpenAlex 2432 FWCI326.287

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

article Full Text OpenAlex 2264 FWCI144.852